Under the Eye of Nr-CAM  by Nguyen-Ba-Charvet, Kim T. & Chédotal, Alain
Neuron 50, 519–529, May 18, 2006 ª2006 Elsevier Inc.PreviewsUnder the Eye of Nr-CAM
Binocular vision relies upon the existence of contralat-
eral and ispilateral projections from retinal ganglion
cells. Contacts between visual axons and optic chiasm
cells are critical for the sorting of crossed and un-
crossed projections during development. In this issue
ofNeuron, a study by Williams et al. shows that the cell
adhesion molecule Nr-CAM facilitates/promotes the
decussation of contralateral axons across the chiasm.
In Drosophila, the combination of cell adhesion mole-
cules (CAMs) expressed on axons has long been known
to play a major role in the control of axon targeting, in
particular of small subsets of motor axons to subsets
of body wall muscles (Goodman, 1996). However, in ver-
tebrates, the axon guidance defects revealed by the
analysis of brain development in several CAM knockout
mice were rather mild compared to the predicted
models, therefore suggesting that, in vertebrates, CAM
function might be highly redundant or rather limited
and associated to additional guidance factors. A novel
study by Williams et al. (2006) shows that this conclusion
is obsolete and that, as originally proposed, CAMs have
an essential role in axon guidance in the vertebrate cen-
tral nervous system (CNS) as in invertebrates by selec-
tively promoting the outgrowth of subsets of axons.
A rapid and irremediable decision that most axons
make during development is to cross or not to cross
the CNS midline. Understanding the molecular mecha-
nism behind this choice has led to some of the most ex-
citing discoveries in developmental neurobiology (Dick-
son, 2002). In mammals, the physiological importance of
having commissural projections is particularly striking in
the visual system. For most mammalian species, the
central region of the visual field is seen by both eyes,
and the ultimate combination of visual stimuli from the
ispilateral eye and the contralateral eye in the visual cor-
tex is the basis of binocular vision (Guillery et al., 1995).
The anatomical correlate of binocular vision is the divi-
sion of the mammalian retina into two distinct areas
that contain retinal ganglion cells (RGCs) projecting to
higher visual centers (the lateral geniculate nucleus in
the thalamus and the superior colliculus) located either
on the same side (ipsilateral projection) or on the oppo-
site side (contralateral projection) of the brain. RGCs
with ipsilateral axons are restricted to the ventro-tempo-
ral crescent (VT), while contralateral ones are concen-
trated in the nasal part (Figure 1A). Moreover, in mam-
mals, the size of their ispilateral retinal quadrant is
proportionally correlated to the size of their binocular vi-
sual field (Guillery et al., 1995). In adult mouse, there are
only about 1000 RCGs with ipsilateral projection, around
2% of the total number of RGCs. Although during early
development (about E14–E17.5 in mouse) the VT only
contains ipsilateral projecting RGCs, later-born VT neu-
rons (about half of the total adult VT population) project
contralaterally (Guillery et al., 1995). The ipsilateral VTpopulation of RGCs has recently been shown to be ge-
netically distinct from the remaining contralateral popu-
lation (Figure 1A). Notably, ipsilateral VT neurons can be
defined as zic-2 and EphB1 positive and islet-2 negative
(Herrera et al., 2003; Williams et al., 2003; Pak et al.,
2004). Within the VT, the late-born contralateral neurons
appear biochemically identical to those found outside
the VT at earlier stages. The novel study by Williams
and collaborators adds four CAMs of the immunoglob-
ulin superfamily (Ig-CAMs) to this flowering list of
molecules enriched in contralaterally projecting RGCs:
neurofascin, NB2, TAG-1, and the neuron-glia cell adhe-
sion molecule-related cell adhesion molecules, better
known as Nr-CAM (Stoeckli, 1998). Nr-CAM and neuro-
fascin belong to a small subfamily of Ig-CAMs, the L1
CAMs, that were isolated in the 1980s by biochemical
methods (Stoeckli, 1998). The four vertebrate members
of this subfamily (L1, CHL1, Nr-CAM, and neurofascin)
are transmembrane proteins with six immunoglobulin
(Ig)-like domains and four to five fibronectin type III mo-
tifs. Like other Ig-CAMs, Nr-CAM is able to mediate ho-
mophilic and heterophilic interactions with a variety of
binding partners and was shown to control the elonga-
tion and fasciculation of a large number of axons, includ-
ing RGC axons (Stoeckli, 1998; Zelina et al., 2005),
and also the formation of the nodes of Ranvier (Eshed
et al., 2005).
In the optic tract, the divergence between crossed
and uncrossed axons from the same eye occurs at the
optic chiasm in the ventral diencephalon. How this seg-
regation is established has been a major research issue
of the last twenty years or so (Guillery et al., 1995). Direct
interaction between axons from the two eyes plays
a role in this process but, more importantly, specific
guidance cues were shown to be expressed in or around
the chiasm by specialized radial glia cells and neurons
(Williams et al., 2003). So far, the identified cues, in par-
ticular ephrin-B2, were found to act as repellents for
crossed axons. However, it is well known that at more
caudal levels in the CNS, midline crossing involves
both repulsive and attracting or growth-promoting
cues (Dickson, 2002). The new study adds an important
missing piece to the puzzle by showing that the guid-
ance of crossed axons across the chiasm is not a default
process, but involves Nr-CAM-mediated attraction.
At all developmental stages, Nr-CAM is more highly
expressed in the optic tract on the distal part of contra-
lateral projecting axons. Accordingly, in chick embryos
that only have crossed RGC axons, Nr-CAM is ex-
pressed all over the retina (Zelina et al., 2005). In both
species, Nr-CAM expression on RGC growth cones in-
creases as they approach the optic disc and chiasm,
and Nr-CAM may thus participate in the initial pathfind-
ing of contralateral RGC axons in the optic cup and tract.
To study Nr-CAM function in RGC axon guidance at the
chiasm, Williams et al. first showed that adding Nr-CAM
function-blocking reagents to whole-mount visual sys-
tem preparations (eye-optic nerve-chiasm) increases
the size of the ipsilateral contingent. Likewise, interfer-
ing with Nr-CAM function in cocultures of chiasm cells
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520with two types of retinal explants, containing a majority
of ipsilaterally projecting neurons (E14.5 VT) or a majority
of contralaterally projecting ones (E14.5–E17.5 non-VT
or E17.5 VT), always results in a strong and selective
Figure 1. Expression and Function of Nr-CAM in the Visual System
of the Newborn Mouse
(A) In wild-type mice (wt), ispilaterally projecting RGCs (red discs)
are confined to the VT. Contralaterally projecting RGCs are found
outside the VT (open green circles), but some are also present in
the VT (green discs). The ipsilateral and contralateral fibers coming
from the same eye diverge at the midline, in the chiasm (blue trian-
gle). The choice to cross or not to cross involves midline radial glial
cells that express several known and unknown repulsive and attrac-
tive guidance factors. In the retina, Nr-CAM is highly expressed in
contraletrally projecting neurons and at a low level in ipsilaterally
projecting RGCs in the VT. The two types of RGCs also express
other specific combination of molecular markers and have distinct
birth dates.
(B) Summary of the chiasm cell/retina explant cocultures. (Left) Ipsi-
laterally projecting axons (from the VT, red) grow poorly on wt chi-
asm cells (blue triangles) compared to controlaterally projecting
ones (VT or non-VT, green). (Right) Nr-CAM function-blocking
agents reduce significantly the growth of contralateral axons on chi-
asm cells and not of ipsilateral ones.
(C) Summary of the wt/Nr-CAM knockout mix-matched cultures.
The growth of contralaterally projecting axons (green) is robust on
chiasm cells from wt (blue triangles, right) or Nr-CAM knockout
(gray triangles, middle). By contrast, the growth of contralateral
axons from Nr-CAM knockout (gray explant, left) is significantly
lower on wt chiasm cells (blue triangle). This suggests that Nr-
CAM acts cell-autonomously on contralaterally projecting RGCs to
promote their growth trough the chiasm.reduction of the length of contralateral RGC axons (Fig-
ure 1B). However, Williams et al., also found that Nr-
CAM is highly expressed at the chiasm by radial glia.
To determine whether Nr-CAM function at the chiasm
is required on contralateral projecting axons or on chi-
asm cells or both, they repeated the chiasm cells/retina
explant cocultures but combining explants and cells
from wild-type and Nr-CAM knockout mice. These ex-
periments showed that in this system, Nr-CAM growth-
promoting activity only requires Nr-CAM expression on
contralateral RGC axons, not on radial glia. Thus,
Nr-CAM primarily acts cell-autonomously, probably as
a receptor on contralateral RGC axons (Figure 1C).
Altogether, these in vitro experiments suggest that Nr-
CAM allows retinal axons to overcome chiasm cell-
mediated repulsion. In order to confirm this hypothesis
in vivo, Williams et al. next performed retrograde tracing
of visual projections in Nr-CAM knockout mice. Surpris-
ingly, no defects were detected at early embryonic ages,
when the ipsilateral projection from the VT is estab-
lished. However, at E18.5, they observed that ipsilateral
RGCs were present at higher density in the VT, whereas
contralateral RGCs were less numerous in the periphery
of the VT. Thus, in vivo Nr-CAM may be only required for
contralateral VT axons to cross the optic chiasm. To de-
termine whether at the chiasm Nr-CAM growth-promot-
ing activity and EphB1/ephrin-B2-mediated repulsion
act synergistically in VT axons, Williams et al. studied
VT projections in Nr-CAM;EphB1 double knockouts.
They found a significant decrease of the ipsilateral con-
tingent in the VT, as observed in EphB1 single knockout
but not in Nr-CAM knockouts. This suggests that the
guidance of ipsilateral VT axons by EphB1/ephrin-B2
and the guidance of contralateral VT axons by Nr-CAM
are two independent and parallel processes.
A role for Nr-CAM in guiding commissural projections
is not without a precedent, as, in the chick spinal cord,
Nr-CAM is required for commissural axons to cross the
floor plate (Stoeckli, 1998). However, the molecular
mechanism must be completely different from the visual
system. In the spinal cord, Nr-CAM, expressed by floor
plate cells, is (or acts as) a ligand for TAG-1/axonin-1
expressed on commissural axons during midline cross-
ing. A recent study has also shown that Nr-CAM signal-
ing controls the development of the anterior commis-
sure in the mouse telencephalon (Falk et al., 2005).
Interestingly, in this system Nr-CAM functions as a
coreceptor for the semaphorin receptor neuropilin-2
and can mediate both growth-promoting and growth-
inhibiting events. This involves the secreted semaphor-
ins, Sema3B and Sema3F. The identity of the Nr-CAM
ligand expressed on chiasm cells remains unknown,
but secreted semaphorins may be good candidates.
First, RGCs express neuropilin-2 and respond to se-
creted semaphorins (Takahashi et al., 1998). Second, in-
terfering with Sema3d expression in zebrafish pertubs
axon guidance at the chiasm (Sakai and Halloran,
2006). The precise expression pattern of these mole-
cules in the VT and chiasm will have to be further ana-
lyzed. Overall, these studies revealed that Nr-CAM is
a major and maybe neglected player in the control of
midline crossing in the vertebrate CNS.
A puzzling result is the apparent normal development
of the crossed pathway from RGCs outside the VT in
GABAB Receptor Isoforms
Caught in Action at the Scene
The metabotropic GABAB receptors mediate slow syn-
aptic inhibition and consist of heterodimers of
GABAB1 and GABAB2 subunits. The only known molec-
ular diversity of the GABAB receptors arises from the
two GABAB1 isoforms, but its functional significance
has been unclear. Two studies in this issue of Neuron
now demonstrate that GABAB1a and GABAB1b show
strategically distinct subcellular localization and phys-
iological action.
Although GABA is the only major inhibitory neurotrans-
mitter in the vertebrate brain, there are many different
modes of inhibition, which act in concert to control syn-
aptic integration, spike generation, and nearly all as-
pects of circuit activity. The GABAergic system seems
to have deployed at least two strategies to greatly enrich
the action of GABA. First, a different ‘‘flavor’’ of GABA is
released by a rich array of interneuron subtypes at dis-
tinct spatial and temporal niches in the neural circuit
(e.g., at different subcellular locations and precisely de-
fined time windows during circuit operation). Second,
different physiological effects of GABA are transmitted
by a large variety of GABA receptors. For example, the
fast component of GABAergic inhibition is mediated by
the ionotropic GABAA receptors. The GABAA receptor
family includes at least 17 genes. Each functional recep-
tor consists of a pentamer of different subunits, which
allows combinatorial coding of different biophysical and
pharmacological properties. In addition, GABA also
activates slow synaptic inhibition through the metabo-
tropic GABAB receptors, which are coupled to hetertri-
meric G proteins. Activation of presynaptic GABAB
receptors located on GABAergic terminals (autorecep-
tors) or other nerve terminals (heteroreceptors) sup-
presses neurotransmitter release, whereas the stimula-
tion of postsynaptic receptors produces a prolonged
neuronal hyperpolarization. Although biochemical and
pharmacological studies have long suggested the pres-
ence of diverse GABAB receptor subtypes (Kerr and Ong,
1995), molecular cloning has only identified two genes
encoding receptor subunits: GABAB1 and GABAB2 (Bet-
tler et al., 2004). It is now fairly well established that most
functional GABAB receptors in the brain are formed as
GABAB1 and GABAB2 heterodimers (Mohler and Frit-
schy, 1999). Therefore, the presumed diversity of native
GABAB receptor subtypes in various in vivo preparations
stands in contrast to the apparent simplicity of their ba-
sic molecular architecture. Two studies led by Bettler
(Vigot et al., 2006) and Larkum (Pe´rez-Garci et al., 2006)
in this issue ofNeuron provide insight to this conundrum
and bring our understanding of the GABAB receptor sys-
tem to a deeper level.
The only firmly established molecular diversity in the
GABAB system thus far arises from the two isoforms of
the GABAB1 subunit: GABAB1a and GABAB1b (Kaupmann
et al., 1998). However, these two isoforms seem to have
very similar pharmacological and biophysical properties
in vitro (Brauner-Osborne and Krogsgaard-Larsen,
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521Nr-CAM knockouts as observed previously in islet-2
knockouts. This suggests that either there is a guidance
mechanism specific for contralateral VT axons or that,
outside the VT, Nr-CAM acts redundantly with other
CAMs or partners. Although Williams et al. showed
that several Ig-CAMs known to interact with Nr-CAM
are expressed by RGCs, none appears specific for con-
tralateral neurons outside the VT. Another important
question will be to determine whether Nr-CAM expres-
sion is regulated by zic-2 and islet-2 transcription fac-
tors, both of which appear to control EphB1 expression.
One may expect Nr-CAM expression in RGCs to be
downregulated in islet-2 knockout and upregulated in
zic-2 knockouts. However, the absence of significant
cross-talk between the EphB1/ephrin-B2 and Nr-CAM
pathways could also signify that their genetic determi-
nation differs. In conclusion, this work by Williams
et al., together with recent studies on VT projections
(Herrera et al., 2003; Williams et al., 2003; Pak et al.,
2004), is setting new standards for the analysis of
crossed and uncrossed visual projections in existing
and forthcoming mouse mutants. This also confirms
that, as originally thought, Ig-CAMs, either as receptors
for slits and netrins or semaphorins or for other un-
known ligands, hold the keys to axon guidance across
the midline.
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